Inconsistent analysis of HER-2 staining results in two different immunohistochemical staining platforms

董芳莉,申敬伟,杨海军
DOI: https://doi.org/10.3760/cma.j.issn.1007-1245.2021.08.024
2021-01-01
Abstract:Objective:To analyze the reasons of the inconsistent results of HER-2 staining in two different immunohistochemical staining platforms.Methods:HER-2 staining was performed in 25 cases of invasive breast cancer and 15 cases of gastric cancer on Roche Ventana XT and Leica Bond Max automatic immunohistochemistry autostainer, respectively, and the results were interpreted strictly in accordance with the HER-2 guidelines.Results:The staining results of HER-2 in Roche Ventana XT and Leica Bond Max staining platforms of 25 cases of invasive breast cancer showed statistically significant difference and poor consistency ( P<0.05, Kappa=0.135). In 15 cases of gastric cancer, there was no statistically significant difference ( P>0.05), but the consistency was poor (Kappa=0.186). Conclusion:In order to improve the quality of pathological sections and promote the standardized operation process, appropriate staining platforms should be selected for different antibodies.
What problem does this paper attempt to address?